Low serum corin levels predict end-organ damage in patients with hypertensive crisis

Burcu Genç Yavuz1, Özgür Söğüt2, Şahin Çolak1

  • 1Department of Emergency Medicine, University of Health Sciences, Haydarpaşa Numune Training and Research Hospital, Istanbul, Turkey.

Insights

Low serum corin levels can help differentiate hypertensive emergency from hypertensive urgency. This biomarker may predict end-organ damage in hypertensive crisis patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Hypertensive crisis (HC) requires prompt differentiation between hypertensive urgency (HU) and hypertensive emergency (HE).
  • Distinguishing HU from HE is crucial for appropriate patient management and preventing end-organ damage.
  • Biomarkers that aid in this differentiation are of significant clinical interest.

Purpose of the Study:

  • To evaluate the predictive value of serum corin levels in differentiating between HU and HE.
  • To assess the association between serum corin levels and end-organ damage in patients with HC.

Main Methods:

  • 120 HC patients and 55 healthy controls were enrolled.
  • Serum corin levels, blood pressure (systolic, diastolic, MAP), and end-organ damage were assessed.
  • Patients were classified as HE or HU based on end-organ damage presence.

Main Results:

  • Serum corin levels were significantly lower in HC patients compared to controls.
  • Serum corin levels were lower in HE patients than in HU patients (p<0.001).
  • A serum corin cutoff of 45 pg/mL distinguished HE from HU with 98.3% sensitivity and 95% specificity.

Conclusions:

  • Serum corin levels are implicated in blood pressure regulation and HC pathogenesis.
  • Low serum corin levels may predict end-organ damage in HC.
  • Serum corin can serve as a diagnostic guide for differentiating HE from HU.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
113
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
272
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
331
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
194
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
112
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
152